MARKET

CUE

CUE

Cue Biopharma Inc
NASDAQ
2.290
-0.080
-3.38%
After Hours: 2.290 0 0.00% 20:05 09/22 EDT
OPEN
2.370
PREV CLOSE
2.370
HIGH
2.370
LOW
2.270
VOLUME
164.99K
TURNOVER
0
52 WEEK HIGH
5.12
52 WEEK LOW
2.180
MARKET CAP
102.96M
P/E (TTM)
-1.8033
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CUE last week (0911-0915)?
Weekly Report · 5d ago
Cue Biopharma Inc: Current report
Press release · 09/14 20:11
Weekly Report: what happened at CUE last week (0904-0908)?
Weekly Report · 09/11 11:06
Weekly Report: what happened at CUE last week (0828-0901)?
Weekly Report · 09/05 01:36
Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying
Benzinga · 08/30 11:49
Weekly Report: what happened at CUE last week (0821-0825)?
Weekly Report · 08/28 11:12
Cue Biopharma: Nothing Stands Out For This Cancer Immunotherapy Developer
Seeking Alpha · 08/10 22:02
Cue Biopharma (CUE) Gets a Buy from Piper Sandler
TipRanks · 08/10 13:16
More
About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a novel class of injectable biologics designed to selectively engage and modulate tumor-specific T cells within the body to treat a broad range of cancers, chronic infectious diseases, and autoimmune diseases. The Company’s proprietary Immuno-STAT (Selective Targeting and Alteration of T Cells) platform harnesses the patient’s intrinsic immune repertoire to fully exploit its potential to fight cancer and restore health while avoiding the deleterious side effects of broad immune activation. The Company’s lead product candidate from the CUE-100 series, CUE-101, is a fusion protein biologic designed to target and activate antigen-specific T cells to fight HPV-driven cancers. Its second drug product candidate, CUE-102, targets Wilms’ Tumor 1 protein (WT-1), an oncofetal antigen. It is also developing CUE-103 and its Neo-STAT and RDI-STAT programs outside of oncology.

Webull offers kinds of Cue Biopharma Inc stock information, including NASDAQ:CUE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CUE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CUE stock methods without spending real money on the virtual paper trading platform.